Ionis Pharmaceuticals Inc (IONS)
37.24
-0.56
(-1.48%)
USD |
NASDAQ |
Nov 14, 16:00
37.25
+0.01
(+0.03%)
After-Hours: 17:54
Ionis Pharmaceuticals Gross Profit (Annual): 778.51M for Dec. 31, 2023
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 778.51M |
| December 31, 2022 | 573.25M |
| December 31, 2021 | 799.61M |
| December 31, 2020 | 717.32M |
| December 31, 2019 | 1.118B |
| December 31, 2018 | 597.85M |
| December 31, 2017 | 514.18M |
| December 31, 2016 | 372.78M |
| December 31, 2015 | |
| December 31, 2014 | |
| December 31, 2013 | |
| December 31, 2012 | |
| December 31, 2011 | |
| December 31, 2010 | |
| December 31, 2009 | 121.60M |
| December 31, 2008 | 107.19M |
| December 31, 2007 |
| Date | Value |
|---|---|
| December 31, 2006 | |
| December 31, 2005 | |
| December 31, 2004 | |
| December 31, 2003 | |
| December 31, 2002 | |
| December 31, 2001 | |
| December 31, 2000 | 42.79M |
| December 31, 1999 | 39.10M |
| December 31, 1998 | 43.50M |
| December 31, 1997 | 35.90M |
| December 31, 1996 | 25.30M |
| December 31, 1995 | 15.80M |
| December 31, 1994 | 13.90M |
| December 31, 1993 | -10.30M |
| December 31, 1992 | 10.70M |
| December 31, 1991 | -5.20M |
| December 31, 1990 | -2.40M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
573.25M
Minimum
2022
1.118B
Maximum
2019
797.38M
Average
778.51M
Median
2023
Gross Profit (Annual) Benchmarks
| Biogen Inc | 7.302B |
| Alnylam Pharmaceuticals Inc | 1.518B |
| Biomarin Pharmaceutical Inc | 1.904B |
| Amicus Therapeutics Inc | 362.03M |
| Arbutus Biopharma Corp | -- |